A study to compare efficacy of posterior sub tenon triamcinolone injection versus intravitreal triamcinolone injection in diabetic macular oedema

A comparison of the efficacy of posterior sub tenon triamcinolone injection and intravitreal triamcinolone injection in diabetic macular oedema patients. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071573

Enrollment

Registered

2024-07-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications

Interventions

Intervention1: Posterior Sub-tenon Triamcinolone Injection and Intravenous Triamcinolone Injection: IVTA injection 4MG in 0.1ml,PST TA injection 40MG in 1ml 1week,1month,3month Intervention2: Posterio

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patient with best corrected visual acuity less than 6/12, patients with clinically significant macular oedema CMT more than 300 micrometers diagnosed by optical coherence tomography, patients with controlled blood sugar level.

Exclusion criteria

Exclusion criteria: 1)Macular oedema due to other causes like retinal vein occlusion, Uveitis etc., Any previous intravitreal triamcinolone and posterior sub tenon triamcinolone injection, previous laser photocoagulation of the retina, Patients with type1 diabetes mellitus, pregnancy induced, stress and juvenile induced diabetes mellitus, any coexisting retinal diseases, Any known hypersensitivity to any component of procedural medication, uncooperative patients with disturbed conscious level.

Design outcomes

Primary

Measure	Time frame
Changes in Visual Acuity and Macular ThicknessTimepoint: 3 months	—

Secondary

Measure	Time frame
IOP Changes, cataract progression and any other procedural complicationTimepoint: 3months	—

Countries

India

Contacts

Public ContactDR MONIKA

Uttar Pradesh University of Medical Sciences

mbdr@live.com7055002070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026